Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 186

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 186
---
corian Fund Management S.à r.l., acting for and on behalf of Generali Financial Holdings            
 FCP-FIS Sub-Fund 2 is Ocorian Holdings (Europe) S.à r.l., which owns 100% of Ocorian Fund Management S.à r.l. Thomas                    
 Fahl, Frederic Pierre Jose Michels and Simon Burgess are the acting and controlling managers of Ocorian Fund Management S.à             
 r.l. The acting and controlling managers of Generali Financial Holdings FCP-FIS Sub-Fund 2 are Thomas Fahl, Frederic Pierre Jose        
 Michels and Simon Burgess. The business address of this stockholder is Cloche d’Or, 17, 2411, Boulevard F.W. Raiffeisen, Luxembourg.    |
| (3) | Consists of: (1) 270,472 Ordinary Shares and (2) 29,208 warrants exercisable into 29,208 Ordinary                                       
 Shares. The beneficial owners under SCP Vitalife Partners II, L.P. are: Jeff Dykan and Avi Ludimursky.                                  |
| (4) | Consists of: (1) 261,780 Ordinary Shares and (2) 29,165 warrants exercisable into 29,165 Ordinary                                       
 shares. The beneficial owner under Medica III Investments (International) LP is Dr. Ehud Geller.                                        |
| (5) | Consists of 261,020 Ordinary Shares. The beneficial owner under DSM is DSM Nederland B.V., which                                        
 is 100% owned by Koninklijke DSM N.V. (or Royal DSM). Koninklijke DSM N.V. is a publicly traded company with Ordinary Shares listed     
 on NYSE Euronext stock exchange in Amsterdam. Koninklijke DSM N.V. currently has no controlling shareholders. The company is managed    
 by a Managing Board together with an Executive Committee and an independent Supervisory Board. Members of the Managing Board and        
 the Supervisory Board are appointed by the General Meeting of Shareholders. The business address of this stockholder is 1 Het Overloon, 
 6411 TE Heerlen, Netherlands.                                                                                                           |
| (6) | Consists of (1) 261,780 Ordinary Shares and warrants to purchase 29,165 Ordinary Shares owned by                                        
 the Medica III Investments (International) L.P, (2) 95,153 Ordinary Shares and warrants to purchase 10,600 Ordinary Shares owned        
 by Medica